Therapeutic Potential of Catechin as an IKK-β Inhibitor for the Management of Arthritis: <i>In vitro</i> and <i>In vivo</i> Approach.

J Pharm Bioallied Sci · 2023 · PMC10790745 · PMID 38235046

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

It is quite significant that, despite the presence of inflammation, catechin administration was found to significantly reduce inflammatory cytokines including IL-17, IL-6, and IL-1β.[ 45 , 46 ] Moreover, there was a favorable association between disease severity and decreased serum and tissue collagen levels.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.